Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.025%.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.025%.".